KARABELAS ARGERIS N 4
4 · REGENXBIO Inc. · Filed Jul 30, 2024
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
KARABELAS ARGERIS N
Director
Transactions
- Exercise/Conversion
Common Stock
2024-07-29$12.74/sh+11,000$140,140→ 22,286 total - Exercise/Conversion
Stock Options (Right to Buy)
2024-07-29−11,000→ 1,500 totalExercise: $12.74Exp: 2026-06-01→ Common Stock (11,000 underlying) - Sale
Common Stock
2024-07-29$15.04/sh−11,000$165,495→ 11,286 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $15.00 to $15.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following June 1, 2016.